These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Usefulness of Vena Contracta for Identifying Severe Secondary Mitral Regurgitation: A Three-Dimensional Transesophageal Echocardiography Study. Author: Onishi H, Izumo M, Naganuma T, Akashi YJ, Nakamura S. Journal: Rev Cardiovasc Med; 2023 Aug; 24(8):233. PubMed ID: 39076725. Abstract: BACKGROUND: In secondary mitral regurgitation (SMR), effective regurgitant orifice area by the proximal isovelocity surface area method ( EROAPISA ) evaluation might cause an underestimation of regurgitant orifice area because of its ellipticity compared with vena contracta area (VCA). We aimed to reassess the SMR severity using VCA-related parameters and EROAPISA . METHODS: The three-dimensional transesophageal echocardiography data of 128 patients with SMR were retrospectively analyzed; the following parameters were evaluated: EROAPISA , anteroposterior and mediolateral vena contracta widths (VCWs) of VCA (i.e., VCWAP and VCWML ), VCWAverage calculated as ( VCWAP + VCWML )/2, and VCAEllipse calculated as π× ( VCWAP /2) × ( VCWML /2). Severe SMR was defined as ≥ 0.39 cm2 . RESULTS: The mean age of the patients was 77.0 ± 8.9 years, and 78 (60.9%) were males. Compared with EROAPISA (r = 0.801), VCWAverage (r = 0.940) and VCAEllipse (r = 0.980) were strongly correlated with VCA. On receiver-operating characteristic curve analysis, VCWAverage and VCAEllipse had C-statistics of 0.981 (95% confidence interval [CI], 0.963-1.000) and 0.985 (95% CI, 0.970-1.000), respectively; these were significantly higher than 0.910 (95% CI, 0.859-0.961) in EROAPISA (p = 0.007 and p = 0.003, respectively). The best cutoff values for severe SMR of VCWAverage and VCAEllipse were 0.78 cm and 0.42 cm2 , respectively. The prevalence of severe SMR significantly increased with an increase in EROAPISA (38 of 88 [43.2%] patients with EROAPISA< 0.30 cm2 , 21 of 24 [87.5%] patients with EROAPISA = 0.30-0.40 cm2 , and 16 of 16 [100%] patients with EROAPISA≥ 0.40 cm2 [Cochran-Armitage test; p< 0.001]). Among patients with EROAPISA< 0.30 cm2 , SMR severity based on VCA was accurately reclassified using VCWAverage (McNemar's test; p = 0.505) and VCAEllipse (p = 0.182). CONCLUSIONS: Among patients who had SMR with EROAPISA of < 0.30 cm2 , suggestive of moderate or less SMR according to current guidelines, > 40% had discordantly severe SMR based on VCA. VCWAverage and VCAEllipse values were useful for identifying severe SMR based on VCA in these patients.[Abstract] [Full Text] [Related] [New Search]